TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Phase 2 Recruiting
110 enrolled
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Phase 2/3 Recruiting
596 enrolled
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Phase 3 Recruiting
480 enrolled
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Phase 2 Recruiting
170 enrolled
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Phase 1 Recruiting
350 enrolled
A Study of ZW251 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
100 enrolled
TroFuse-019
Phase 3 Recruiting
780 enrolled
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Phase 1 Recruiting
100 enrolled
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 Recruiting
392 enrolled
Krascendo 2
Phase 3 Recruiting
600 enrolled
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Phase 1/2 Recruiting
191 enrolled
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Recruiting
350 enrolled
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Phase 1/2 Recruiting
252 enrolled
MK-3475-01F
Phase 1/2 Recruiting
190 enrolled
AURORA
Phase NA Recruiting
43 enrolled
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 3 Recruiting
1,410 enrolled
A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer
Phase 2 Recruiting
200 enrolled
NSCLC
Phase 2 Recruiting
60 enrolled
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Phase 2 Recruiting
40 enrolled
Be6A Lung-02
Phase 3 Recruiting
714 enrolled
MountainTAP-29
Phase 2/3 Recruiting
590 enrolled
REZILIENT4
Phase 3 Recruiting
360 enrolled
LARCS
Recruiting
512 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 5 FDA
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Phase 1 Recruiting
55 enrolled
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Phase 1 Recruiting
188 enrolled
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Phase 1/2 Recruiting
295 enrolled
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer
Phase 2 Recruiting
180 enrolled
Dabrafenib and/or Trametinib Rollover Study
Phase 4 Recruiting
100 enrolled
MK-3475-01I
Phase 2 Recruiting
144 enrolled
MK-3475-01E
Phase 2 Recruiting
60 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
VISUALIZE-2
Phase 3 Recruiting
132 enrolled
Agni-01
Phase 1/2 Recruiting
208 enrolled
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
340 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Phase 1 Recruiting
226 enrolled
SUNRAY-01
Phase 3 Recruiting
1,264 enrolled
ALKAZAR
Phase 3 Recruiting
450 enrolled
European Real-World Registry for Use of the Ion Endoluminal System
Recruiting
1,200 enrolled
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Phase 1 Recruiting
280 enrolled
CASCADE
Recruiting
600 enrolled
TARGET
Phase NA Recruiting
25 enrolled
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
132 enrolled
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer
Phase 2 Recruiting
35 enrolled
KANNON-5
Phase 2 Recruiting
40 enrolled
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 Recruiting
134 enrolled
PROSPER
Phase 1/2 Recruiting
403 enrolled
BA-004
Phase NA Recruiting
2,063 enrolled
VELOCITY-Lung
Phase 2 Recruiting
270 enrolled